Suven Life Sciences announces positive topline results from Phase-2 PoC signal detection open label study of Ropanicant
The primary objective was to evaluate safety and tolerability of Ropanicant in patients with MDD
The primary objective was to evaluate safety and tolerability of Ropanicant in patients with MDD
Eugia Steriles receives EIR from USFDA for new injectable facility
MoU signed to drive digital transformation through strategic projects across all three business sectors of Merck
He has been associated with Caplin Steriles Ltd., Mylan Laboratories Ltd., Caplin Point Laboratories Ltd., Strides Arcolab Ltd. and Novartis Vaccines and Diagnostics
Wacker Biotech will manufacture the active ingredients of MinervaX’s novel vaccine candidate
Total investment incurred for setting up the new R&D Rs 250 crore
Target identification will commence on 17 September 2024, following the timeline provided in the campaign guidelines
The award is for development of Nafithromycin, which is the first ever multi-drug resistant pathogen active respiratory antibiotic for the treatment of Community-Acquired Bacterial Pneumonia
Tecentriq Hybreza provides patients and physicians with greater flexibility of treatment options while showing safety and efficacy consistent with intravenous
Fluoxetine Tabs 60 mg approval solidifies the company's position in the molecule by complementing the recent approval in April 2024 for Fluoxetine 10 mg and 20 mg tablets and Fluoxetine capsules
Subscribe To Our Newsletter & Stay Updated